These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Role of Long-Acting Muscarinic Antagonist/Long-Acting β Petite SE Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560 [TBL] [Abstract][Full Text] [Related]
3. LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD. Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Thach C; Patalano F; Banerji D; Int J Chron Obstruct Pulmon Dis; 2015; 10():1015-26. PubMed ID: 26082625 [TBL] [Abstract][Full Text] [Related]
4. Dual LABA/LAMA Therapy versus LABA or LAMA Monotherapy for Chronic Obstructive Pulmonary Disease. A Systematic Review and Meta-analysis in Support of the American Thoracic Society Clinical Practice Guideline. Mammen MJ; Pai V; Aaron SD; Nici L; Alhazzani W; Alexander PE Ann Am Thorac Soc; 2020 Sep; 17(9):1133-1143. PubMed ID: 32530702 [No Abstract] [Full Text] [Related]
8. Long-acting muscarinic antagonist + long-acting beta agonist versus long-acting beta agonist + inhaled corticosteroid for COPD: A systematic review and meta-analysis. Horita N; Miyazawa N; Tomaru K; Inoue M; Kaneko T Respirology; 2015 Nov; 20(8):1153-9. PubMed ID: 26235837 [TBL] [Abstract][Full Text] [Related]
9. Respiratory pharmacotherapy use in patients newly diagnosed with chronic obstructive pulmonary disease in a primary care setting in the UK: a retrospective cohort study. Wurst KE; Shukla A; Muellerova H; Davis KJ COPD; 2014 Sep; 11(5):521-30. PubMed ID: 24945236 [TBL] [Abstract][Full Text] [Related]
11. Comparative Effectiveness of Long-Acting Beta Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405 [TBL] [Abstract][Full Text] [Related]
12. Long-Acting β-Agonists (LABA) Combined With Long-Acting Muscarinic Antagonists or LABA Combined With Inhaled Corticosteroids for Patients With Stable COPD. Horita N; Nagashima A; Kaneko T JAMA; 2017 Oct; 318(13):1274-1275. PubMed ID: 28973232 [TBL] [Abstract][Full Text] [Related]
13. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design. Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416 [TBL] [Abstract][Full Text] [Related]
14. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis. Rodrigo GJ; Price D; Anzueto A; Singh D; Altman P; Bader G; Patalano F; Fogel R; Kostikas K Int J Chron Obstruct Pulmon Dis; 2017; 12():907-922. PubMed ID: 28360514 [TBL] [Abstract][Full Text] [Related]
15. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes. Hizawa N Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659 [TBL] [Abstract][Full Text] [Related]
16. Prognostic and functional impact of perioperative LAMA/LABA inhaled therapy in patients with lung cancer and chronic obstructive pulmonary disease. Azuma Y; Sano A; Sakai T; Koezuka S; Otsuka H; Tochigi N; Isobe K; Sakamoto S; Takai Y; Iyoda A BMC Pulm Med; 2021 May; 21(1):174. PubMed ID: 34020622 [TBL] [Abstract][Full Text] [Related]
17. Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis. Hurst JR; Dilleen M; Morris K; Hills S; Emir B; Jones R Int J Chron Obstruct Pulmon Dis; 2018; 13():781-792. PubMed ID: 29551894 [TBL] [Abstract][Full Text] [Related]
18. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy. Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905 [TBL] [Abstract][Full Text] [Related]
19. [Medication management of COPD]. Gueçamburu M; Zysman M Rev Prat; 2024 Jan; 74(1):7-12. PubMed ID: 38329243 [TBL] [Abstract][Full Text] [Related]
20. [The stepwise approach of COPD therapy]. Watz H; Kirsten A; Greulich T Dtsch Med Wochenschr; 2019 Jan; 144(1):15-20. PubMed ID: 30602182 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]